Reference : The hematopoietic factor granulocyte-colony stimulating factor improves outcome in ex...
Scientific journals : Article
Life sciences : Biochemistry, biophysics & molecular biology
Systems Biomedicine
http://hdl.handle.net/10993/26989
The hematopoietic factor granulocyte-colony stimulating factor improves outcome in experimental spinal cord injury.
English
Pitzer, Claudia mailto [> Sygnis Bioscience]
Klussmann, Stefan [German Cancer Research Center > Department of Molecular Neurobiology]
Krüger, Carola [> Sygnis Bioscience]
Letellier, Elisabeth mailto [German Cancer Research Center]
Plaas, Christian [> Sygnis Bioscience]
Dittgen, Tanjew [> Sygnis Bioscience]
Kirsch, Friederike [> Sygnis Bioscience]
Stieltjes, Bram [German Cancer Research Center > Department of Radiology]
Weber, Daniela [> Sygnis Bioscience]
Laage, Rico [> Sygnis Bioscience]
Martin-Villalba, Ana [German Cancer Research Center > Department of Molecular Neurobiology]
Schneider, Armin [> Sygnis Bioscience]
May-2010
Journal of Neurochemistry
Blackwell
113
930-942
Yes
International
0022-3042
1471-4159
Oxford
United Kingdom
[en] Granulocyte-colony stimulating factor (G-CSF) ; spinal cord injury.
[en] Granulocyte-colony stimulating factor (G-CSF) is a potent hematopoietic factor that drives differentiation of neutrophilic granulocytes. We have recently shown that G-CSF also acts as a neuronal growth factor, protects neurons in vitro and in vivo, and has regenerative potential in various neurological disease models. Spinal cord injury (SCI) following trauma or secondary to skeletal instability is a terrible condition with no effective therapies available at present. In this study, we show that the G-CSF receptor is up-regulated upon experimental SCI and that G-CSF improves functional outcome in a partial dissection model of SCI. G-CSF significantly decreases apoptosis in an experimental partial spinal transsection model in the mouse and increases expression of the anti-apoptotic G-CSF target gene Bcl-X(L). In vitro, G-CSF enhances neurite outgrowth and branching capacity of hippocampal neurons. In vivo, G-CSF treatment results in improved functional connectivity of the injured spinal cord as measured by Mn(2+)-enhanced MRI. G-CSF also increased length of the dorsal corticospinal tract and density of serotonergic fibers cranial to the lesion center. Mice treated systemically with G-CSF as well as transgenic mice over-expressing G-CSF in the CNS exhibit a strong improvement in functional outcome as measured by the BBB score and gridwalk analysis. We show that G-CSF improves outcome after experimental SCI by counteracting apoptosis, and enhancing connectivity in the injured spinal cord. We conclude that G-CSF constitutes a promising and feasible new therapy option for SCI.
http://hdl.handle.net/10993/26989
10.1111/j.1471-4159.2010.06659.x

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
The hematopoietic factor granulocyte-colony factor improves outcome in experimental spinal cord injury.docxAuthor preprint13.85 kBView/Open

Bookmark and Share SFX Query

All documents in ORBilu are protected by a user license.